Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Other Publications
    • ajnr

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.


AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

Research ArticleINTERVENTIONAL

n-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial

The n-BCA Trial Investigators
American Journal of Neuroradiology May 2002, 23 (5) 748-755;
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 1.

    PVA group treatment flow chart.

  • Fig 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 2.

    n-BCA group treatment flow chart.

Tables

  • Figures
    • View popup
    TABLE 1:

    Arteriovenous malformations and patient characteristics

    n-BCAPVA
    Number of patients5250
    Spetzler grade, mean (number in each grade 1–5)2.9(5,13,20,11,3)2.9(5,14,17,10,3)
    Volume(cm3)22.221.7
    >6 cm44
    Deep venous drainage2623
    Age (mean years)40.537.6
    Sex33 male: 19 female27 male: 23 female
    History
     Intracerebral hemorrhage1412
     Subarachnoid hemorrhage73
     Seizures2421
     Altered mental status66
     Pounding/pulsatile headache1415
    Physical examination deficits
     Vision77
     Motor/Coordination1011
     Sensory66
     Speech46
     Mentation63
    % Pretreatment Glasgow Outcome Scale score = 593.5%87.5%
    • Note.—n-BCA indicates n-butyl cyanoacrylate; PVA, polyvinyl alcohol.

    • View popup
    TABLE 2:

    Treatment parameters

    n-BCAPVA
    Number of patients5249
    Number of stages7786
    Duration of embolization (min)178168
    Duration of fluoroscopy (total min)93.8109.6
    Coils used (stages)1561*
    Coils used (mean)204(14.4)**559(10.0)%
    Number of patients, no coils used399
    Particle size used among procedures
     <500 μm18(36.7%)
     <500 μm only, no coils5(10.6%)
     500–710 μm42(29.6%)
     710–1000 μm22(15.5%)
     1000–1400 μm5(3.5%)
    Infusion catheters
     3-French infusion31(31.3%)53(52%)
     Flow-directed catheter62(62.6%)33(32.4%)
     Other6(6.1%)16(15.7%)
    Guidewires
     0.01805(3.8%)
     0.01610(11.5%)28(21.5%)
     0.01411(12.6%)34(26.2%)
     0.01051(58.6%)41(31.5%)
    • Note.—n-BCA indicates n-bytyl cyanoacrylate; PVA, polyvinyl alcohol.

    • * P < .0001.

    • ** 95 coils used in one patient.

    • View popup
    TABLE 3:

    Transfusions/fluid replacement, surgery time

    n-BCAPVA
    Number of patients transfused1313
    Number of units transfused (mean, median, range)51 (3.4, 2, 1–16)135 (10.4, 3,1–61)
    Fluid, colloid replacement (cc)39184053
    Surgery min (mean)381 (n = 41)413 (n = 42)
    • Note.—n-BCA indicates n-butyl cyanoacrylate; PVA, polyvinyl alcohol.

    • View popup
    TABLE 4:

    Incidence of complications

    Complicationsn-BCA (n = 54)PVA (n = 52)
    Seizure5(9.3%)5(9.6%)
    Catheter glued inside vessel4(7.4%)0(0.0%)
    Late polymerization3(5.6%)0(0.0%)
    Occluded catheter3(5.6%)5(9.6%)
    Parenchymal hemorrhage3(5.6%)6(11.5%)
    Vasospasm3(5.6%)7(13.5%)
    AVM rupture2(3.7%)1(1.9%)
    Early polymerization2(3.7%)0(0.0%)
    Inability to subselect vessel2(3.7%)4(7.7%)
    CVA (stroke)2(3.7%)3(5.8%)
    Death1(1.9%)3(5.8%)
    Hematoma1(1.9%)1(1.9%)
    Incorrect vessel(s) occluded1(1.9%)0(0.0%)
    Infection/inflammation1(1.9%)0(0.0%)
    Over-the-wire system could not be advanced1(1.9%)1(1.9%)
    Thromboembolism1(1.9%)1(1.9%)
    Vessel dissection1(1.9%)1(1.9%)
    Vessel perforation1(1.9%)3(5.8%)
    Cranial ischemia (TIA)0(0.0%)2(3.8%)
    Catheter rupture0(0.0%)1(1.9%)
    Failure to access vessel0(0.0%)2(3.8%)
    Flow too high for safe infusion of embolic agent0(0.0%)2(3.8%)
    Headache0(0.0%)2(3.8%)
    Pulmonary embolism0(0.0%)1(1.9%)
    Subarachnoid hemorrhage0(0.0%)2(3.8%)
    Provocative test failed0(0.0%)1(1.9%)
    Uncooperative patient0(0.0%)2(3.8%)
    Other9(16.7%)9(17.3%)
    • Note.—n-BCA indicates n-butyl cyanoacrylate; PVA, polyvinyl alcohol; AVM, arteriovenous malformation; CVA, cerebrovascular accident; TIA, transient ischemic attack.

    • View popup
    TABLE 5:

    Hemorrhagic complications

    n-BCA (n = 54)PVA (n = 52)
    Total hemorrhagic complications7(13.0%)15(28.9%)
    Vessel perforation, SAH* using 3- or 1.9-French OTW catheter1(1.9%)3(5.8%)
    Vessel perforation, SAH* using flow-guided catheter only01(1.9%)
    Postembolization, presurgical intracerebral hemorrhage4(7.4%)3(5.8%)
    Postoperative hemorrhage2(3.7%)**8(15.4%)**
    AVM volume cm3 mean (range)21.8(10.4–32.4)20.2(6.3–105.3)
    Deep venous drainage (n)26
    Coils, mean, range12, 0–2417.4, 0–50
    • Note.—n-BCA indicates n-butyl cyanoacrylate; PVA, polyvinyl alcohol; SAH, subarachnoid hemorrhage; AVM, arteriovenous malformation.

    • * Subarachnoid hemorrhage identified on early postembolization CT scan; not identified at fluoroscopy.

    • ** P < .05 in intent-to-treat analysis.

PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 23 (5)
American Journal of Neuroradiology
Vol. 23, Issue 5
1 May 2002
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
n-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
The n-BCA Trial Investigators
n-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial
American Journal of Neuroradiology May 2002, 23 (5) 748-755;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
n-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial
The n-BCA Trial Investigators
American Journal of Neuroradiology May 2002, 23 (5) 748-755;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Primary Efficacy Results
    • Secondary Efficacy Results
    • Safety Results
    • Discussion
    • Conclusion
    • Appendix
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Morbidity and mortality associated with sequential flow reduction embolization technique of cerebral arteriovenous malformations using n-butyl cyanoacrylate
  • Management of Brain Arteriovenous Malformations: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
  • Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis
  • N-butyl cyanoacrylate embolization using a detachable tip microcatheter: initial experience
  • Augmentation of N-butyl cyanoacrylate embolization of cranial, head, and neck tumors by simultaneous infusion of 5% dextrose solution
  • Hemorrhagic Complications after Endovascular Treatment of Cerebral Arteriovenous Malformations
  • Angioarchitectural Characteristics Associated with Complications of Embolization in Supratentorial Brain Arteriovenous Malformation
  • Randomized clinical trials: the double edged sword
  • Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Recommendations: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
  • Microsurgical retrieval of an endovascular microcatheter trapped during Onyx embolization of a cerebral arteriovenous malformation
  • Treatment of Brain Arteriovenous Malformations by Double Arterial Catheterization with Simultaneous Injection of Onyx: Retrospective Series of 17 Patients
  • A single-surgeon randomized trial comparing sutures, N-butyl-2-cyanoacrylate and human fibrin glue for mesh fixation during primary inguinal hernia repair
  • Adjuvant Embolization With N-Butyl Cyanoacrylate in the Treatment of Cerebral Arteriovenous Malformations: Outcomes, Complications, and Predictors of Neurologic Deficits
  • Preoperative Embolization of Cerebral Arteriovenous Malformations with Onyx
  • Brain Aneurysms and Arteriovenous Malformations: Advancements and Emerging Treatments in Endovascular Embolization
  • Arteriovenous malformations of the brain: ready to randomise?
  • Scottish Intracranial Vascular Malformation Study (SIVMS): Evaluation of Methods, ICD-10 Coding, and Potential Sources of Bias in a Prospective, Population-Based Cohort
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • SAVE vs. Solumbra Techniques for Thrombectomy
  • CT Perfusion&Reperfusion in Acute Ischemic Stroke
  • Delayed Reperfusion Post-Thrombectomy&Thrombolysis
Show more Interventional

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editors Choice
  • Fellow Journal Club
  • Letters to the Editor

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • Special Collections

Resources

  • News and Updates
  • Turn around Times
  • Submit a Manuscript
  • Author Policies
  • Manuscript Submission Guidelines
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Submit a Case
  • Become a Reviewer/Academy of Reviewers
  • Get Peer Review Credit from Publons

Multimedia

  • AJNR Podcast
  • AJNR SCANtastic
  • Video Articles

About Us

  • About AJNR
  • Editorial Board
  • Not an AJNR Subscriber? Join Now
  • Alerts
  • Feedback
  • Advertise with us
  • Librarian Resources
  • Permissions
  • Terms and Conditions

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire